These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24684676)

  • 1. Role of CDH1 promoter methylation in colorectal carcinogenesis: a meta-analysis.
    Li YX; Lu Y; Li CY; Yuan P; Lin SS
    DNA Cell Biol; 2014 Jul; 33(7):455-62. PubMed ID: 24684676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between p16 gene promoter methylation and clinicopathologic features of colorectal cancer: a meta-analysis of 27 cohort studies.
    Chen YZ; Liu D; Zhao YX; Wang HT; Gao Y; Chen Y
    DNA Cell Biol; 2014 Oct; 33(10):729-38. PubMed ID: 24979649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CDH1 promoter polymorphism and DNA methylation in bladder carcinogenesis: a meta-analysis.
    Wang Y; Kong CZ; Zhang Z; Yang CM; Li J
    DNA Cell Biol; 2014 Apr; 33(4):205-16. PubMed ID: 24491043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant promoter methylation of the vimentin gene may contribute to colorectal carcinogenesis: a meta-analysis.
    Li YW; Kong FM; Zhou JP; Dong M
    Tumour Biol; 2014 Jul; 35(7):6783-90. PubMed ID: 24729088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter methylation of the RASSF1A gene may contribute to colorectal cancer susceptibility: a meta-analysis of cohort studies.
    Wang HL; Liu P; Zhou PY; Zhang Y
    Ann Hum Genet; 2014 May; 78(3):208-16. PubMed ID: 24621386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of p16 gene promoter methylation in gastric carcinogenesis: a meta-analysis.
    Wang HL; Zhou PY; Liu P; Zhang Y
    Mol Biol Rep; 2014 Jul; 41(7):4481-92. PubMed ID: 24610350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant promoter methylation of the SFRP1 gene may contribute to colorectal carcinogenesis: a meta-analysis.
    Chen YZ; Liu D; Zhao YX; Wang HT; Gao Y; Chen Y
    Tumour Biol; 2014 Sep; 35(9):9201-10. PubMed ID: 24929326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant promoter methylation of RASSF1A gene may be correlated with colorectal carcinogenesis: a meta-analysis.
    Wang HL; Zhang Y; Liu P; Zhou PY
    Mol Biol Rep; 2014 Jun; 41(6):3991-9. PubMed ID: 24566684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of RASSF1A promoter methylation in the pathogenesis of ovarian cancer: a meta-analysis.
    Si JG; Su YY; Han YH; Chen RH
    Genet Test Mol Biomarkers; 2014 Jun; 18(6):394-402. PubMed ID: 24665911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant Methylation of T-cadherin Can Be a Diagnostic Biomarker for Colorectal Cancer.
    Duan BS; Xie LF; Wang Y
    Cancer Genomics Proteomics; 2017; 14(4):277-284. PubMed ID: 28647701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between CDH1 promoter methylation and patients with ovarian cancer: a systematic meta-analysis.
    Wang Q; Wang B; Zhang YM; Wang W
    J Ovarian Res; 2016 Apr; 9():23. PubMed ID: 27067410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of toll-like receptor 4 in colorectal carcinogenesis: a meta-analysis.
    Li XX; Sun GP; Meng J; Li X; Tang YX; Li Z; Wang MF; Liang GF; Lu XB
    PLoS One; 2014; 9(4):e93904. PubMed ID: 24705379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms in the IL-18 gene and ulcerative colitis risk: a meta-analysis.
    Wang Y; Tong J; Chang B; Wang BF; Zhang D; Wang BY
    DNA Cell Biol; 2014 Jul; 33(7):438-47. PubMed ID: 24621393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological significance and potential drug targeting of CDH1 in lung cancer: a meta-analysis and literature review.
    Yu Q; Guo Q; Chen L; Liu S
    Drug Des Devel Ther; 2015; 9():2171-8. PubMed ID: 25931811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of MTHFR genetic polymorphisms on toxicity and clinical response of irinotecan-based chemotherapy in patients with colorectal cancer.
    Li P; Chen Q; Wang YD; Ha MW
    Genet Test Mol Biomarkers; 2014 May; 18(5):313-22. PubMed ID: 24611457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin (CDH1) gene -160C/A polymorphism and the risk of colorectal cancer: A meta-analysis involving 17,291 subjects.
    Ye CC; Wang J
    J Gene Med; 2021 Oct; 23(10):e3370. PubMed ID: 34097324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of genetic variants in and promoter hypermethylation of CDH1 with gastric cancer: a meta-analysis.
    Jing H; Dai F; Zhao C; Yang J; Li L; Kota P; Mao L; Xiang K; Zheng C; Yang J
    Medicine (Baltimore); 2014 Oct; 93(19):e107. PubMed ID: 25340495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review.
    Huang R; Ding P; Yang F
    Drug Des Devel Ther; 2015; 9():5277-85. PubMed ID: 26425077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CDH13 promoter methylation in the carcinogenesis, progression, and prognosis of colorectal cancer: A systematic meta-analysis under PRISMA guidelines.
    Ye M; Huang T; Li J; Zhou C; Yang P; Ni C; Chen S
    Medicine (Baltimore); 2017 Jan; 96(4):e5956. PubMed ID: 28121942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant promoter methylation of SOCS-1 gene may contribute to the pathogenesis of hepatocellular carcinoma: a meta-analysis.
    Zhao RC; Zhou J; He JY; Wei YG; Qin Y; Li B
    J BUON; 2016; 21(1):142-51. PubMed ID: 27061542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.